Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1964 1
1965 1
1966 1
1968 1
1969 1
1970 1
1971 5
1972 2
1974 3
1975 1
1977 1
1978 1
1979 2
1981 1
1982 5
1983 4
1984 4
1985 2
1986 3
1987 2
1988 4
1989 3
1990 3
1991 3
1992 1
1993 5
1994 8
1995 2
1996 6
1997 2
1999 1
2000 2
2001 1
2002 3
2003 3
2004 3
2005 2
2006 4
2007 2
2008 1
2009 3
2010 5
2011 5
2012 7
2013 3
2014 3
2015 2
2016 2
2017 8
2018 10
2019 6
2020 6
2021 6
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Percutaneous cholecystoscopy.
Inui K, Nakazawa S, Yoshino J, Yamao K, Naito Y, Kimoto E, Asai T. Inui K, et al. Among authors: kimoto e. Endoscopy. 1989 Dec;21 Suppl 1:361-4. doi: 10.1055/s-2007-1012991. Endoscopy. 1989. PMID: 2606086
[Squamous cell carcinoma of the extrahepatic bile duct].
Funakawa T, Fujishiro N, Kuno N, Kobayashi S, Kimoto E, Suzuki K. Funakawa T, et al. Among authors: kimoto e. Ryoikibetsu Shokogun Shirizu. 1996;(9):61-3. Ryoikibetsu Shokogun Shirizu. 1996. PMID: 8705560 Review. Japanese. No abstract available.
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y, Varma M, Feng B, Stephens JC, Kimoto E, El-Kattan A, Ichikawa K, Kikkawa H, Ono C, Suzuki A, Suzuki M, Yamamoto Y, Tremaine L. Lai Y, et al. Among authors: kimoto e. Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):723-43. doi: 10.1517/17425255.2012.678048. Epub 2012 Apr 18. Expert Opin Drug Metab Toxicol. 2012. PMID: 22509796 Review.
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 Synthesis.
McClure KF, Piotrowski DW, Petersen D, Wei L, Xiao J, Londregan AT, Kamlet AS, Dechert-Schmitt AM, Raymer B, Ruggeri RB, Canterbury D, Limberakis C, Liras S, DaSilva-Jardine P, Dullea RG, Loria PM, Reidich B, Salatto CT, Eng H, Kimoto E, Atkinson K, King-Ahmad A, Scott D, Beaumont K, Chabot JR, Bolt MW, Maresca K, Dahl K, Arakawa R, Takano A, Halldin C. McClure KF, et al. Among authors: kimoto e. Angew Chem Int Ed Engl. 2017 Dec 18;56(51):16218-16222. doi: 10.1002/anie.201708744. Epub 2017 Nov 24. Angew Chem Int Ed Engl. 2017. PMID: 29073340
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19.
Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, Beutler N, Binder J, Chen E, Eng H, Hammond H, Hammond J, Haupt RE, Hoffman R, Kadar EP, Kania R, Kimoto E, Kirkpatrick MG, Lanyon L, Lendy EK, Lillis JR, Logue J, Luthra SA, Ma C, Mason SW, McGrath ME, Noell S, Obach RS, O'Brien MN, O'Connor R, Ogilvie K, Owen D, Pettersson M, Reese MR, Rogers TF, Rossulek MI, Sathish JG, Shirai N, Steppan C, Ticehurst M, Updyke LW, Weston S, Zhu Y, Wang J, Chatterjee AK, Mesecar AD, Frieman MB, Anderson AS, Allerton C. Boras B, et al. Among authors: kimoto e. bioRxiv. 2021 Feb 12:2020.09.12.293498. doi: 10.1101/2020.09.12.293498. Preprint. bioRxiv. 2021. PMID: 32935104 Free PMC article. Updated.
159 results